Thompson Siegel & Walmsley LLC Cuts Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Thompson Siegel & Walmsley LLC lowered its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 15.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 852,419 shares of the company's stock after selling 150,622 shares during the quarter. Thompson Siegel & Walmsley LLC owned approximately 0.68% of Henry Schein worth $58,987,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Versant Capital Management Inc lifted its stake in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% during the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after buying an additional 569 shares during the last quarter. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% during the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares during the last quarter. Finally, City State Bank bought a new position in Henry Schein during the fourth quarter worth about $55,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price objective on the stock. Wells Fargo & Company assumed coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price objective for the company. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Stock Performance

Shares of NASDAQ:HSIC traded up $1.22 on Monday, hitting $71.80. 2,009,568 shares of the company were exchanged, compared to its average volume of 1,505,096. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The stock's 50 day moving average price is $74.84 and its 200 day moving average price is $72.62. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $8.92 billion, a P/E ratio of 29.55, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same quarter in the previous year, the firm posted $0.66 earnings per share. The company's quarterly revenue was up 5.8% on a year-over-year basis. Sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.